Pharmaceutical firms developing lipid-lowering medicines

Published: 2009-09-14 06:59:00
Updated: 2009-09-14 06:59:00
Korean pharmaceutical firms are preparing to challenge AstraZeneca’s grip on the lipid-lowering medicine market with generics of rosuvastatin, according to the Korea Food and Drug Administration.

According to the drug authorities, 29 local drug makers, which have thrown their hat into the rin...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.